Adalimumab ELISA
Enzyme immunoassay for the quantitative determination of free Adalimumab (Humira®) in serum and plasma.
The solid phase (MTP) is coated by the target molecule, in this case TNF-alpha.
Reference: IG-AA103
Barcode: 8682754930097
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research, diagnostic and biosimilar uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AA103 692.04 KB
Material Safety Data Sheet (MSDS) IG-AA103 268.18 KB
Quality Control Certificates
Quality Control Certificate Lot: AA103-108 292.64 KB
Quality Control Certificate Lot: AA103-107 294.75 KB
Quality Control Certificate Lot: AA103-106 296.47 KB
Quality Control Certificate Lot: AA103-105 289.21 KB
Quality Control Certificate Lot: AA103-104 157.73 KB
Quality Control Certificate Lot: AA103-103 157.80 KB
Quality Control Certificate Lot: AA103-102 160.18 KB
Quality Control Certificate Lot: AA103-12 78.81 KB
Humira® is a trademark of Abbott Laboratories.
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 105 |
| Sample | Serum or Plasma |
| Package Size | 96 Tests |
| Standard Range (ng/mL, 10x) | 0-2000 |
| Detection Limit (ng/mL) | 5 |
| Spike Recovery (%) | >95 |
| Shelf Life (years) | 2 |
Standard Curve:
